Equine Healthcare Market by Product (Drugs, Vaccines and Supplemental Feed Additives) by Disease (West Nile Virus, Equine Rabies, Equine Influenza, Equine Herpes Virus, Potomac Horse Fever and Others), by Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies and Drug Stores and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

April 2018 | 110 pages | ID: E878FD18FA5EN
Zion Market Research

Abstracts

The report covers forecast and analysis for the equine healthcare market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Million). The study includes drivers and restraints for the equine healthcare market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the equine healthcare market on a global level. In order to give the users of this report a comprehensive view on the equine healthcare market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type segment, disease type segment and distribution channel segment are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the equine healthcare market by segmenting the market based on product type, disease type, by distribution channel and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2023. Based on product type the market is segmented into drug type, vaccine type, and supplemental feed additives. Based on disease type the market is segmented into west nile virus, equine rabies, equine influenza, equine herpes virus, potomac horse fever and others category. Based on distribution channel the market is segmented into veterinary hospitals and clinics, retail pharmacies and drug stores and others category. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries. This segmentation includes demand for equine healthcare market based on product type, disease type and distribution channel in all the regions and countries.

The report also includes detailed profiles of end players such as Bayer AG (Bayer Animal Health), Boehringer Ingelheim, Ceva Sant Animale, Eli Lilly and Company (Elanco), Equine Products U.K. Ltd., Merck Co. (Merck Animal Health), Sanofi (Merial), Purina Animal Nutrition LLC, Vetoquinol S.A., Zoetis and Others.

This report segments the global equine healthcare market as follows:

Global Equine Healthcare Market: Product Type Segment Analysis

• Drug Type
• Anti-Infectives
• Anti-Inflammatory
• Parasiticides
• Others
• Vaccine Type
• Inactivated
• Live Attenuated
• Recombinant
• Others
• Supplemental Feed Additives

Global Equine Healthcare Market: Diseases Segment Analysis

• West Nile Virus
• Equine Rabies
• Equine Influenza
• Equine Herpes Virus
• Potomac Horse Fever
• Others

Global Equine Healthcare Market: Distribution Channel Method Analysis

• Veterinary Hospitals And Clinics
• Retail Pharmacies And Drug Stores
• Others

Global Equine Healthcare Market: Regional Segment Analysis

• North America
• The U.S.
• Europe
• UK
• France
• Germany
• Asia Pacific
• China
• Japan
• India
• Latin America
• Brazil
• Middle East and Africa

Contents

CHAPTER 1. INTRODUCTION

1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
  1.3.1. Market research process
  1.3.2. Market research methodology

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Global equine healthcare market, 2017 2023 (USD Million)
2.2. Global equine healthcare market: snapshot

CHAPTER 3. EQUINE HEALTHCARE MARKET MARKET DYNAMICS

3.1. Introduction
3.2. Market Drivers
  3.2.1. Global equine healthcare market drivers: impact analysis
  3.2.2. Rising incidence of equine infections
  3.2.3. Initiatives by equine healthcare organizations and market participants
3.3. Market Restraints
  3.3.1. Global equine healthcare market restraints: impact analysis
  3.3.2. The decline in global equine population
3.4. Opportunities
  3.4.1. The rise in demand for pet insurance
3.5. Porters five forces analysis
  3.5.1. Bargaining power of suppliers
  3.5.2. Bargaining power of buyers
  3.5.3. The threat from new entrants
  3.5.4. Threat from new substitutes
  3.5.5. Degree of competition
3.6. Market Attractiveness Analysis
  3.6.1. Market attractiveness analysis, by product type segment
  3.6.2. Market attractiveness analysis, by diseases type segment
  3.6.3. Market attractiveness analysis, by distribution channel segment
  3.6.4. Market attractiveness analysis, by regional segment

CHAPTER 4. GLOBAL EQUINE HEALTHCARE MARKET COMPETITIVE LANDSCAPE

4.1. Company market share analysis
  4.1.1. Global equine healthcare market: company market share, 2017
4.2. Strategic development
  4.2.1. Acquisitions mergers
  4.2.2. New therapy launch
  4.2.3. Agreements, partnerships, collaborations and joint ventures
  4.2.4. Research and development and regional expansion
4.3. Price trend analysis

CHAPTER 5. GLOBAL EQUINE HEALTHCARE MARKET PRODUCT TYPE ANALYSIS

5.1. Global equine healthcare market: Product type overview
  5.1.1. Global equine healthcare market revenue share, by product type, 2017 and 2023
5.2. Drug Type
  5.2.1. Global equine healthcare market for drug type, 2017 2023 (USD Million)
    5.2.1.1. Anti-Infectives
      5.2.1.1.1. Global anti-infectives market, 2016 2022 (USD Million)
    5.2.1.2. Anti-Inflammatory
      5.2.1.2.1. The global anti-inflammatory market, 2016 2022 (USD Million)
    5.2.1.3. Parasiticides
      5.2.1.3.1. Global parasiticides market, 2016 2022 (USD Million)
    5.2.1.4. Others
      5.2.1.4.1. Global others market, 2016 2022 (USD Million)
5.3. Vaccine Type
  5.3.1. Global equine healthcare market for vaccine type, 2017 2023 (USD Million)
    5.3.1.1. Inactivated
      5.3.1.1.1. Global inactivated market, 2016 2022 (USD Million)
    5.3.1.2. Live Attenuated
      5.3.1.2.1. Global live attenuated market, 2016 2022 (USD Million)
    5.3.1.3. Recombinant
      5.3.1.3.1. Global recombinant market, 2016 2022 (USD Million)
    5.3.1.4. Others
      5.3.1.4.1. Global others market, 2016 2022 (USD Million)
5.4. Supplemental Feed Additives
  5.4.1. Global equine healthcare market for supplemental feed additives, 2017 2023 (USD Million)

CHAPTER 6. GLOBAL EQUINE HEALTHCARE MARKET DISEASES TYPE ANALYSIS

6.1. Global equine healthcare market: Diseases type overview
  6.1.1. Global equine healthcare market revenue share, by disease type, 2017 and 2023
6.2. West Nile Virus
  6.2.1. Global equine healthcare market for west nile virus, 2017 2023 (USD Million)
6.3. Equine Influenza
  6.3.1. Global equine healthcare market for equine influenza, 2017 2023 (USD Million)
6.4. Equine Herpes Virus
  6.4.1. Global equine healthcare market for equine herpes virus, 2017 2023 (USD Million)
6.5. Potomac Horse Fever
  6.5.1. Global equine healthcare market for potomac horse fever, 2017 2023 (USD Million)
6.6. Others
  6.6.1. Global equine healthcare market for others, 2017 2023 (USD Million)

CHAPTER 7. GLOBAL EQUINE HEALTHCARE MARKET DISTRIBUTION CHANNEL ANALYSIS

7.1. Global equine healthcare market: distribution channel overview
  7.1.1. Global equine healthcare market revenue share, by distribution channel, 2017 and 2023
7.2. Veterinary Hospitals and Clinics
  7.2.1. Global equine healthcare market for veterinary hospitals and clinics, 2017 2023 (USD Million)
7.3. Retail Pharmacies and Drug Stores
  7.3.1. Global equine healthcare market for retail pharmacies and drug stores, 2017 2023 (USD Million)
7.4. Others
  7.4.1. Global equine healthcare market for others, 2017 2023 (USD Million)

CHAPTER 8. GLOBAL EQUINE HEALTHCARE MARKET REGIONAL SEGMENT ANALYSIS

8.1. Global equine healthcare market: regional overview
  8.1.1. Global equine healthcare market revenue share, by region, 2017 and 2023
8.2. North America
  8.2.1. North America equine healthcare market revenue, by product type, 2017 2023 (USD Million)
  8.2.2. North America equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
  8.2.3. North America equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.2.4. U.S.
    8.2.4.1. U.S. equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.2.4.2. U.S. equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.2.4.3. U.S. equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.2.5. Rest of North America
    8.2.5.1. Rest of North America equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.2.5.2. Rest of North America equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.2.5.3. Rest of North America equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.3. Europe
  8.3.1. Europe equine healthcare market revenue, by product type, 2017 2023 (USD Million)
  8.3.2. Europe equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
  8.3.3. Europe equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.3.4. U.K.
    8.3.4.1. U.K. equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.3.4.2. U.K. equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.3.4.3. U.K. equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.3.5. Germany
    8.3.5.1. Germany equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.3.5.2. Germany equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.3.5.3. Germany equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.3.6. France
    8.3.6.1. France equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.3.6.2. France equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.3.6.3. France equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.3.7. Rest of Europe
    8.3.7.1. Rest of Europe equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.3.7.2. Rest of Europe equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.3.7.3. Rest of Europe equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.4. Asia Pacific
  8.4.1. Asia Pacific equine healthcare market revenue, by product type, 2017 2023 (USD Million)
  8.4.2. Asia Pacific equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
  8.4.3. Asia Pacific equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.4.4. China
    8.4.4.1. China equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.4.4.2. China equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.4.4.3. China equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.4.5. Japan
    8.4.5.1. Japan equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.4.5.2. Japan equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.4.5.3. Japan equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.4.6. India
    8.4.6.1. India equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.4.6.2. India equine healthcare market revenue, by diseases, 2017 2023 (USD Million)
    8.4.6.3. India equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.4.7. Rest of Asia Pacific
    8.4.7.1. Rest of Asia Pacific equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.4.7.2. Rest of Asia Pacific equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.4.7.3. Rest of Asia Pacific equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.5. Latin America
  8.5.1. Latin America equine healthcare market revenue, by product type, 2017 2023 (USD Million)
  8.5.2. Latin America equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
  8.5.3. Latin America equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.5.4. Brazil
    8.5.4.1. Brazil equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.5.4.2. Brazil equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.5.4.3. Brazil equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.5.5. Mexico
    8.5.5.1. Mexico equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.5.5.2. Mexico equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.5.5.3. Mexico equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.5.6. Rest of Latin America
    8.5.6.1. Rest of Latin America equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.5.6.2. Rest of Latin America equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.5.6.3. Rest of Latin America equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.6. Middle East and Africa
  8.6.1. Middle East and Africa equine healthcare market revenue, by product type, 2017 2023 (USD Million)
  8.6.2. Middle East and Africa equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
  8.6.3. Middle East and Africa equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.6.4. Saudi Arabia
    8.6.4.1. Saudi Arabia equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.6.4.2. Saudi Arabia equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.6.4.3. Saudi Arabia equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.6.5. UAE
    8.6.5.1. UAE equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.6.5.2. UAE equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.6.5.3. UAE equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.6.6. South Africa
    8.6.6.1. South Africa equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.6.6.2. South Africa equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.6.6.3. South Africa equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
  8.6.7. Rest of Middle East and Africa
    8.6.7.1. Rest of Middle East and Africa equine healthcare market revenue, by product type, 2017 2023 (USD Million)
    8.6.7.2. Rest of Middle East and Africa equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
    8.6.7.3. Rest of Middle East and Africa equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)

CHAPTER 9. COMPANY PROFILES

9.1. Bayer AG (Bayer Animal Health)
  9.1.1. Overview
  9.1.2. Financials
  9.1.3. Therapy portfolio
  9.1.4. Business strategy
  9.1.5. Recent developments
9.2. Boehringer Ingelheim
  9.2.1. Overview
  9.2.2. Financials
  9.2.3. Therapy portfolio
  9.2.4. Business strategy
  9.2.5. Recent developments
9.3. Ceva Sant Animale
  9.3.1. Overview
  9.3.2. Financials
  9.3.3. Therapy portfolio
  9.3.4. Business strategy
  9.3.5. Recent developments
9.4. Eli Lilly and Company (Elanco)
  9.4.1. Overview
  9.4.2. Financials
  9.4.3. Therapy portfolio
  9.4.4. Business strategy
  9.4.5. Recent developments
9.5. Equine Products U.K. Ltd.
  9.5.1. Overview
  9.5.2. Financials
  9.5.3. Therapy portfolio
  9.5.4. Business strategy
  9.5.5. Recent developments
9.6. Merck Co. (Merck Animal Health)
  9.6.1. Overview
  9.6.2. Financials
  9.6.3. Therapy portfolio
  9.6.4. Business strategy
  9.6.5. Recent developments
9.7. Sanofi (Merial)
  9.7.1. Overview
  9.7.2. Financials
  9.7.3. Therapy portfolio
  9.7.4. Business strategy
  9.7.5. Recent developments
9.8. Purina Animal Nutrition LLC]
  9.8.1. Overview
  9.8.2. Financials
  9.8.3. Therapy portfolio
  9.8.4. Business strategy
  9.8.5. Recent developments
9.9. Vetoquinol S.A.
  9.9.1. Overview
  9.9.2. Financials
  9.9.3. Therapy portfolio
  9.9.4. Business strategy
  9.9.5. Recent developments
9.10. Zoetis
  9.10.1. Overview
  9.10.2. Financials
  9.10.3. Therapy portfolio
  9.10.4. Business strategy
  9.10.5. Recent developments